Invention Grant
- Patent Title: Human anti-semaphorin 4D antibody
-
Application No.: US16611209Application Date: 2018-05-04
-
Publication No.: US11427634B2Publication Date: 2022-08-30
- Inventor: Ernest S. Smith , Angelica Cornelison , Maria G. M. Scrivens , Mark Paris , Maurice Zauderer
- Applicant: VACCINEX, INC.
- Applicant Address: US NY Rochester
- Assignee: VACCINEX, INC.
- Current Assignee: VACCINEX, INC.
- Current Assignee Address: US NY Rochester
- Agency: KDB Firm PLLC
- International Application: PCT/US2018/031263 WO 20180504
- International Announcement: WO2018/204895 WO 20181108
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/00 ; C07K16/46 ; C07K16/28 ; A61K39/00
Abstract:
Compositions and method are provided for treating diseases associated with semaphorin-4D (SEMA4D) pathology, including autoimmune diseases, inflammatory diseases, cancers, neuroinflammatory disorders and neurodegenerative diseases.
Public/Granted literature
- US20210032329A1 HUMAN ANTI-SEMAPHORIN 4D ANTIBODY Public/Granted day:2021-02-04
Information query
